General Information of the Compound
| Compound ID |
CP0522131
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,5-dimethylphenyl)-2-[[4-(furan-2-ylmethyl)-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-pyridin-2-ylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H25N5O3S
|
||||||||||||||||||
| Molecular Weight |
499.596
|
||||||||||||||||||
| Canonical SMILES |
Cc1occc1-c1nnc(SCC(=O)N(c2cc(C)cc(C)c2)c2ccccn2)n1Cc1ccco1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H25N5O3S/c1-18-13-19(2)15-21(14-18)32(24-8-4-5-10-28-24)25(33)17-36-27-30-29-26(23-9-12-34-20(23)3)31(27)16-22-7-6-11-35-22/h4-15H,16-17H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
LSOZHNVGNFSYQN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1